Combination antiangiogenic tyrosine kinase inhibition and anti-PD1 immunotherapy in metastatic renal cell carcinoma: A retrospective analysis of safety, tolerance, and clinical outcomes
抗血管生成酪氨酸激酶抑制剂联合抗PD-1免疫疗法治疗转移性肾细胞癌:安全性、耐受性和临床疗效的回顾性分析
期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.3812
Laccetti, Andrew L; Garmezy, Benjamin; Xiao, Lianchun; Economides, Minas; Venkatesan, Aradhana; Gao, Jianjun; Jonasch, Eric; Corn, Paul; Zurita-Saavedra, Amado; Brown, Landon C; Kao, Chester; Kinsey, Emily N; Gupta, Rajan T; Harrison, Michael R; Armstrong, Andrew J; George, Daniel J; Tannir, Nizar; Msaouel, Pavlos; Shah, Amishi; Zhang, Tian; Campbell, Matthew T
肿瘤
肿瘤免疫
信号转导
肾癌
血管生成
细胞生物学
PD-1
免疫/内分泌